蘇 鈺凱

Medicine & Life Sciences

1. Glioblastoma 100%
2. Traumatic Brain Injury 66%
3. Temozolomide 50%
4. garcinol 49%
5. Neoplastic Stem Cells 42%
6. Mental Fatigue 39%
7. Glioma 32%
8. ovatodiolide 28%
9. 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 26%
10. acalabrutinib 26%
11. Down-Regulation 22%
12. Radiosurgery 19%
13. Planning Techniques 19%
14. Brain 19%
15. Catenins 18%
16. STAT3 Transcription Factor 17%
17. Hyperbaric Oxygenation 17%
18. Brain Neoplasms 16%
19. Triple Negative Breast Neoplasms 16%
20. Exosomes 15%
21. Sleep 15%
22. Arteriovenous Malformations 15%
23. Carcinogenesis 15%
24. Intracranial Hemorrhages 15%
25. Intracranial Pressure 14%
26. Fluoroscopy 14%
27. Sirolimus 14%
28. Central Nervous System Cysts 13%
29. Amyloid 12%
30. 4-acetylantroquinonol B 12%
31. Integrins 12%
32. Arachnoid Cysts 12%
33. Reproducibility of Results 11%
34. Renal Insufficiency 11%
35. Case-Control Studies 11%
36. Phenotype 11%
37. Cysts 11%
38. Renal Dialysis 11%
39. Neoplasms 11%
40. Vascular Endothelial Growth Factor A 11%
41. Stem Cells 11%
42. Fatigue 11%
43. Publications 11%
44. Therapeutics 11%
45. Minimally Invasive Surgical Procedures 10%
46. Cognition 10%
47. Meta-Analysis 10%
48. Blood Vessels 9%
49. Recurrence 9%
50. Oxygen 9%